Oaktree Acquisition Corp. III Life Sciences (OACC) Shares Outstanding (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences has reported Shares Outstanding for 3 years, with the latest figure at $192.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 3900.0% year-over-year to $192.0 million; the trailing twelve-month figure through Mar 2026 stood at $192.0 million (up 3900.0% YoY), and the FY2025 full-year result was $583981.0, down 87.83% from the prior year.
• Shares Outstanding for Q1 2026 stood at $192.0 million, up from $583981.0 in the prior quarter.
• The five-year high for Shares Outstanding was $192.0 million in Q1 2026, with the low at $583981.0 in Q4 2024.
• Historically, Shares Outstanding has averaged $34.6 million across 3 years, with a median of $4.8 million in 2025.
• Annual changes were most pronounced in 2025 — Shares Outstanding plunged 87.83% — and 2026, when it soared 3900.0%.
• Oaktree Acquisition Corp. III Life Sciences' Shares Outstanding stood at $4.8 million in 2024, then sank by 87.83% to $583981.0 in 2025, then surged by 32776.12% to $192.0 million in 2026.
• The last three Shares Outstanding figures came in at $192.0 million (Q1 2026), $583981.0 (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.